Recent Expansions With the recent expansion of facilities to Somerville, Massachusetts, Charles River Laboratories is strategically positioning itself in an emerging life sciences hub, presenting an opportunity for increased collaboration and business growth in the region.
Technological Innovation The launch of innovative technologies such as Modular and Fast Track viral vector technology and the Virtual Control Groups initiative showcases Charles River Laboratories' commitment to advancing research processes. Leveraging these cutting-edge technologies can be a compelling selling point to attract forward-thinking clients seeking efficiency and the latest advancements.
Partnership with Sanofi Partnering with Sanofi to set aside animal testing demonstrates Charles River Laboratories' alignment with ethical and sustainable practices. This collaboration presents a unique opportunity to engage with clients who prioritize animal welfare and eco-consciousness in their research and development endeavors.
Market Focus: Gene Therapy The launch of the Viral Vector Tech Transfer program to safeguard Gene Therapy development reflects Charles River Laboratories' specialization in an evolving and high-demand sector. This focused offering can be positioned as a competitive advantage to attract clients seeking expertise and reliable support in the Gene Therapy market.
Strategic Hire in Asia Pacific Bringing Baht on board as the head of the Asia Pacific region signals Charles River Laboratories' intent to strengthen its presence in a key market. Leveraging Baht's experience and network can unlock potential business opportunities and establish stronger relationships with clients in the Asia Pacific region.
Charles River Laboratories uses 8 technology products and services including Medallia, Canva, Blackline, and more. Explore Charles River Laboratories's tech stack below.
| Charles River Laboratories Email Formats | Percentage |
| first.last@crl.com | 92% |
| last@crl.com | 3% |
| last.first@crl.com | 1% |
| first.middle@crl.com | 1% |
| flast@crl.com | 1% |
| filast@crl.com | 1% |
| first.middlelast@crl.com | 0% |
| first.l@crl.com | 1% |
| fir.last@crl.com | 0% |
| lf@crl.com | 0% |
| firstmiddle.last@crl.com | 0% |
| firstlast@crl.com | 0% |
| first@crl.com | 0% |
| flast@criver.com | 62% |
| first.last@criver.com | 34% |
| lfirst@criver.com | 3% |
| first@criver.com | 1% |
| flast@agiluxlabs.com | 72% |
| first_last@agiluxlabs.com | 10% |
| filast@agiluxlabs.com | 3% |
| first_l@agiluxlabs.com | 3% |
| firstl@agiluxlabs.com | 3% |
| first.l@agiluxlabs.com | 3% |
| first-last@agiluxlabs.com | 3% |
| last.first@agiluxlabs.com | 3% |
Biotechnology ResearchMassachusetts, United States10001+ Employees
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
Company Overview
Media & News
Funding & FinancialsCharles River Laboratories has raised a total of $1B of funding over 4 rounds. Their latest funding round was raised on Mar 23, 2021.
Charles River Laboratories's revenue is in the range of $1B
Funding & FinancialsCharles River Laboratories has raised a total of $1B of funding over 4 rounds. Their latest funding round was raised on Mar 23, 2021.
Charles River Laboratories's revenue is in the range of $1B
Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com